MasTec, Inc. (MTZ) Reports In-Line Q2 EPS; Guides Q3, FY14

MasTec, Inc. (NYSE: MTZ) reported Q2 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.09 billion.

MasTec, Inc. sees FY2014 EPS of $1.55-$1.58, versus the consensus of $1.82. MasTec, Inc. sees FY2014 revenue of $4.4-4.5 billion, versus the consensus of $4.54 billion.

MasTec, Inc. sees Q3 2014 EPS of $0.56, versus the consensus of $0.61. MasTec, Inc. sees Q3 2014 revenue of $1.30-1.35 billion, versus the consensus of $1.26 billion.

For earnings history and earnings-related data on MasTec, Inc. (MTZ) click here.

You May Also Be Interested In

• Clover Health Investments (CLOV) Tops Q3 EPS by 1c ; Offers Guidance
• AppLovin (APP) Tops Q3 EPS by 26c, Beats on Revenue; Offers Q4 Revenue Guidance
• Edwards Lifesciences (EW) Tops Q3 EPS by 6c; raises guidance